Nuwellis, Inc. Announces First Quarter 2024 Financial Results
Nuwellis, Inc. (NUWE)
Company Research
Source: GlobeNewswire
MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial results for the first quarter ended March 31, 2024. Highlights: Revenue of $1.9 million, a 2% increase over the prior-year period.Consumables sales, representing 82% of total revenue, grew 11% year-over-year.Pediatric revenue growth of 40% year over year led by a 54% increase in consumable sales.Gross margin of 64.1%, compared to 58.4% in the prior year period.Received FDA clearance for an additional dual lumen extended length catheter.Launched Aquadex® ultrafiltration therapy for heart failure patients as a part of Nuwellis’ pivotal REVERSE-HF clinical study at Henry Ford Health.Company anticipates significant expense reductions – approaching 50% – through efficiency initiatives for the rest of the calendar year. “We are pleased to see firm utilization, led by Pediatrics and
Show less
Read more
Impact Snapshot
Event Time:
NUWE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NUWE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NUWE alerts
High impacting Nuwellis, Inc. news events
Weekly update
A roundup of the hottest topics
NUWE
News
- Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in FloridaGlobeNewswire
- Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration TherapyGlobeNewswire
- Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT TechnologyGlobeNewswire
- Nuwellis Announces Closing of $2.7 Million Public OfferingGlobeNewswire
- Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024GlobeNewswire
NUWE
Sec Filings
- 5/17/24 - Form ARS
- 5/17/24 - Form DEFR14A
- 5/8/24 - Form 10-Q
- NUWE's page on the SEC website